New tests and new treatments are presenting more options for certain patients with Alzheimer's disease. “Today a confluence ...

TORONTO -- The antiviral agent valacyclovir demonstrated no benefit in early Alzheimer's disease, the phase II VALAD trial ...

TORONTO -- Blood tests for Alzheimer's disease biomarkers can be used clinically -- and can replace expensive brain scans and ...

Adopting intensive lifestyle changes can slow or stop progression of early-stage Alzheimer’s disease, according to a new ...

Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related dementia (ADRD), sparking hope for potential interventions to prevent the ...

The idea that herpes infections trigger or contribute to Alzheimer's disease has been gaining favor among some scientists, ...

A major Alzheimer’s disease medical group is recommending that specialists may use certain blood tests to help diagnose ...

A pair of FDA-approved cancer drugs may help reverse the biological changes that drive Alzheimer’s disease, according to a ...

The combination of a recently approved blood test for detection of Alzheimer's disease combined with two medications that slow progression of the disease is drastically improving outcomes for patients ...

Cognito’s OVERTURE trial demonstrated significant ‘time saved’ in functional and cognitive decline at both six and 18 months.

Amyloids are perhaps best known as a key driver of Alzheimer's disease. The amorphous proteins, found throughout the human ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope. “Alzheimer’s disease is a specific condition resulting from an abnormal biological ...